Skip to main content

Syndicate contentVienna

AFFiRiS AG: Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing

November 19, 2009 by prandd

Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing

Are sterile mosquitoes the answer to malaria elimination?

The Sterile Insect Technique (SIT), the release of sexually sterile male insects to wipe out a pest population, is one suggested solution to the problem of malaria in Africa. A new supplement, published in BioMed Central's open access Malaria Journal, reviews the history of the technique, and features details about aspects of its application in the elimination of malaria.

Austrian Nano Initiative a Success

November 12, 2009 by prandd

Vienna, 11 November 2009 (BMVIT). The "NANO: Wissenschaft. Wirtschaft. Wirkung.

BMVIT Showcases the Austrian NANO Initiative.

November 2, 2009 by prandd

"NANO: Science. Industry. Impact. 09" at Tech Gate Vienna November 9, 2009

A New "Space Age": Globalisation Is Shaping Urban Development

October 29, 2009 by prandd

"Space" is defined and shaped by social forces. A project at the Vienna University of Technology is presently investigating how current changes in these forces are impacting on urban development.

AFFiRiS AG: Encouraging Results from Phase I Studies of Two Alzheimer's Candidate Vaccines Trigger EUR 10 Mio. Milestone Payment

October 20, 2009 by prandd

Vienna, 20. October 2009: AFFiRiS AG today announced that the primary endpoints have been met for the Phase I clinical studies of its two Alzheimer's vaccines AD01 and AD02, which demonstrated favourable safety and tolerability profiles. These results trigger a 10 million EUR milestone payment from licensee GlaxoSmithKline Biologicals.

Under Observation - Restless Atoms Cause Materials to Age

September 14, 2009 by prandd

Atoms have the habit of jumping through solids - a practice that physicists have recently been able to follow for the first time using a brand new method. This scientific advance was made possible thanks to the utilisation of cutting-edge X-ray sources, known as electron synchrotrons.

New laser technique may help find supernova

One single atom of a certain isotope of hafnium found on Earth would prove that a supernova once exploded near our solar system. The problem is how to find such an atom - among billions of others. Researchers at the University of Gothenburg, Sweden, have developed a laser technique that, in combination with standard techniques, may be able to do the job.

Predictors of disease behavior change in Crohn?s disease

Using the Vienna classification system, it has been shown in clinic-based cohorts that there can be a significant change in disease behavior over time, whereas disease location remains relatively stable. Clinical and environmental factors as well as medical therapy might be relevant in predicting disease behavior change in patients with CD.

The Austrian Atheist Campaign’s adverts in Vienna

July 22, 2009 by BlueGenes

BlueGenes's picture

Those of you that have been paying attention to PZ Myers may be aware that some humanists in Austria managed to put adverts on buses in Vienna. That's not quite correct, but close enough: they weren't able to find anyone willing to publish their adverts on buses, but were able to advertise on static billboards, so they didn't have to stoop to renting their own bus and driving through the country, like the German equivalent did in May. For maximum effect, click here to read this post in it's original location

PTSD Increases Risk of Dementia in Veterans

July 20, 2009 by mcole

According to a new study veterans diagnosed with Post-Traumatic Stress Disorder (PTSD) have a significantly higher risk of developing dementia compared to those veterans without PTSD.

Memory test and PET scans detect early signs of Alzheimer's

Berkeley -- A large study of patients with mild cognitive impairment revealed that results from cognitive tests and brain scans can work as an early warning system for the subsequent development of Alzheimer's disease.

Alzheimer's disease drug treats traumatic brain injury, report GUMC researchers

Vienna, Austria -- The destructive cellular pathways activated in Alzheimer's disease are also triggered following traumatic brain injury, say researchers from Georgetown University Medical Center (GUMC). They say this finding suggests that novel therapy might successfully target both conditions.

Mount Sinai researchers find new Alzheimer's disease treatment promising

(New York, NY -- July 12, 2009) -- Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The two investigators, Giulio Maria Pasinetti, M.D., Ph.D.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes